Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.prnewswire.com/news-releases/rational-vaccines-announces-a-clinical-trial-to-determine-baseline-characteristics-of-patients-diagnosed-with-recurrent-symptomatic-herpes-simplex-type--2-hsv-2-virus-301605324.html
0
0
Rational Vaccines Announces a Clinical Trial to Determine Baseline Characteristics of Patients Diagnosed With Recurrent Symptomatic Herpes Simplex Type 2 (HSV-2) Virus - PR Newswire
8/15/22 at 5:00am
Organization
PRNewswire
Authors
Details
46 words
Summarize
Infectious Diseases
Medical Procedures
Health
Public Health
Rational Vaccines Announces a Clinical Trial
T2DM
HSV-2
PRNewswire
/PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, today announced the...
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...